Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA

NCT02787278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: SP-8203 High dose
DRUG: SP-8203 Low dose
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.